Gene · 3981
Papers3,259
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,259
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel insights into the ecDNA formation mechanism involving MSH3 in methotrexate‑resistant human colorectal cancer cells. | Int J Oncol | 2023 | 37888748 | PubTator, text mining | PubMed |
| DNA damage and repair: underlying mechanisms leading to microcephaly. | Front Cell Dev Biol | 2023 | 37881689 | PubTator, text mining | PubMed |
| Deficiency of ligase IV leads to reduced NHEJ, accumulation of DNA damage, and can sensitize cells to cancer therapeutics. | Genomics | 2023 | 37871849 | PubTator, text mining | PubMed |
| Structural and functional basis of inositol hexaphosphate stimulation of NHEJ through stabilization of Ku-XLF interaction. | Nucleic Acids Res | 2023 | 37870477 | PubTator, text mining | PubMed |
| Chromatin compartmentalization regulates the response to DNA damage. | Nature | 2023 | 37853125 | PubTator, text mining | PubMed |
| lhCLIP reveals the in vivo RNA-RNA interactions recognized by hnRNPK. | PLoS Genet | 2023 | 37851698 | PubTator, text mining | PubMed |
| New Facets of DNA Double Strand Break Repair: Radiation Dose as Key Determinant of HR versus c-NHEJ Engagement. | Int J Mol Sci | 2023 | 37834403 | PubTator, text mining | PubMed |
| Genetic and Functional Modifications Associated with Ovarian Cancer Cell Aggregation and Limited Culture Conditions. | Int J Mol Sci | 2023 | 37834315 | PubTator, text mining | PubMed |
| Gene expression of non-homologous end-joining pathways in the prognosis of ovarian cancer. | iScience | 2023 | 37810216 | PubTator, text mining | PubMed |
| Double-strand DNA break repair: molecular mechanisms and therapeutic targets. | MedComm (2020) | 2023 | 37808268 | PubTator, text mining | PubMed |
| How to fix DNA breaks: new insights into the mechanism of non-homologous end joining. | Biochem Soc Trans | 2023 | 37787023 | PubTator, text mining | PubMed |
| A genome-wide CRISPR/Cas9 screen identifies DNA-PK as a sensitiser to 177Lutetium-DOTA-octreotate radionuclide therapy. | Theranostics | 2023 | 37771787 | PubTator, text mining | PubMed |
| Targeting DNA Damage Repair and Immune Checkpoint Proteins for Optimizing the Treatment of Endometrial Cancer. | Pharmaceutics | 2023 | 37765210 | PubTator, text mining | PubMed |
| Impact of Treatment with Ustekinumab on Severe Infections in a Patient with Uncontrolled Psoriasis and Late-Onset Combined Primary Immunodeficiency: Case Report. | Pathogens | 2023 | 37764964 | PubTator, text mining | PubMed |
| Disseminated Mycobacterium genavense Infection Mimicking Sarcoidosis: A Case Report and Review of Literature on Japanese Patients. | Microorganisms | 2023 | 37763989 | PubTator, text mining | PubMed |
| Class I HDAC Inhibition Leads to a Downregulation of FANCD2 and RAD51, and the Eradication of Glioblastoma Cells. | J Pers Med | 2023 | 37763083 | PubTator, text mining | PubMed |
| Ataxia Telangiectasia Arising as Immunodeficiency: The Intriguing Differential Diagnosis. | J Clin Med | 2023 | 37762981 | PubTator, text mining | PubMed |
| TDP-43 Epigenetic Facets and Their Neurodegenerative Implications. | Int J Mol Sci | 2023 | 37762112 | PubTator, text mining | PubMed |
| Simulating Space Conditions Evokes Different DNA Damage Responses in Immature and Mature Cells of the Human Hematopoietic System. | Int J Mol Sci | 2023 | 37762064 | PubTator, text mining | PubMed |
| RNF126, 168 and CUL1: The Potential Utilization of Multi-Functional E3 Ubiquitin Ligases in Genome Maintenance for Cancer Therapy. | Biomedicines | 2023 | 37760968 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3981/papers?page=9